Advertisement

Related Videos

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Opening Session Panel Discussion

Opportunities to Optimize Cancer Policies Panel Discussion

Advertisement

Advertisement




Nov
09
Today In Oncology
Extended Follow-up of Nivolumab Ipilimumab for Localized dMMR MSI-H Gastric GEJ Cancer
Claudia Henschke, PhD, MD Finding Lung Cancer in Time
HERON-Lung01 HER3-Directed ADC Prolongs PFS in EGFR-Mutated Advanced NSCLC
ROSELLA Subgroup Analysis Supports Relacorilant Use in Patients Previously Treated With Taxanes
Long-Term Survivors of Hodgkin Lymphoma May Face Elevated Health Risks, Study Finds
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo